Literature DB >> 23784628

Structure-function analysis of the human ferroportin iron exporter (SLC40A1): effect of hemochromatosis type 4 disease mutations and identification of critical residues.

Gérald Le Gac1, Chandran Ka, Rozenn Joubrel, Isabelle Gourlaouen, Pierre Lehn, Jean-Paul Mornon, Claude Férec, Isabelle Callebaut.   

Abstract

Ferroportin (SLC40A1) is the only known iron exporter in mammals and is considered a key coordinator of the iron balance between intracellular and systemic iron homeostasis. However, the structural organization of ferroportin in the lipid bilayer remains controversial and very little is known about the mechanism underlying iron egress. In the present study, we have developed an approach based on comparative modeling, which has led to the construction of a model of the three-dimensional (3D) structure of ferroportin by homology to the crystal structure of a Major Facilitator Superfamily member (EmrD). This model predicts atomic details for the organization of ferroportin transmembrane helices and is in agreement with our current understanding of the ferroportin function and its interaction with hepcidin. Using in vitro experiments, we demonstrate that this model can be used to identify novel critical amino acids. In particular, we show that the tryptophan residue 42 (p.Trp42), which is localized within the extracellular end of the ferroportin pore, is likely involved in both the iron export function and in the mechanism of inhibition by hepcidin. Thus, our 3D model provides a new perspective for understanding the molecular basis of ferroportin functions and dysfunctions.
© 2013 WILEY PERIODICALS, INC.

Entities:  

Keywords:  Major Facilitator Superfamily; ferroportin; hemochromatosis; molecular modeling

Mesh:

Substances:

Year:  2013        PMID: 23784628     DOI: 10.1002/humu.22369

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  15 in total

1.  Loss-of-function ferroportin disease: novel mechanistic insights and unanswered questions.

Authors:  L Tom Vlasveld; Dorine W Swinkels
Journal:  Haematologica       Date:  2018-11       Impact factor: 9.941

2.  Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.

Authors:  Sharraya Aschemeyer; Bo Qiao; Deborah Stefanova; Erika V Valore; Albert C Sek; T Alex Ruwe; Kyle R Vieth; Grace Jung; Carla Casu; Stefano Rivella; Mika Jormakka; Bryan Mackenzie; Tomas Ganz; Elizabeta Nemeth
Journal:  Blood       Date:  2017-12-13       Impact factor: 22.113

Review 3.  Ceruloplasmin-ferroportin system of iron traffic in vertebrates.

Authors:  Giovanni Musci; Fabio Polticelli; Maria Carmela Bonaccorsi di Patti
Journal:  World J Biol Chem       Date:  2014-05-26

4.  Structural comparison, substrate specificity, and inhibitor binding of AGPase small subunit from monocot and dicot: present insight and future potential.

Authors:  Kishore Sarma; Priyabrata Sen; Madhumita Barooah; Manabendra D Choudhury; Shubhadeep Roychoudhury; Mahendra K Modi
Journal:  Biomed Res Int       Date:  2014-09-02       Impact factor: 3.411

5.  Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin.

Authors:  Reiya Taniguchi; Hideaki E Kato; Josep Font; Chandrika N Deshpande; Miki Wada; Koichi Ito; Ryuichiro Ishitani; Mika Jormakka; Osamu Nureki
Journal:  Nat Commun       Date:  2015-10-13       Impact factor: 14.919

Review 6.  Targeting iron metabolism in drug discovery and delivery.

Authors:  Bart J Crielaard; Twan Lammers; Stefano Rivella
Journal:  Nat Rev Drug Discov       Date:  2017-02-03       Impact factor: 84.694

7.  Insights into the Role of the Discontinuous TM7 Helix of Human Ferroportin through the Prism of the Asp325 Residue.

Authors:  Marlène Le Tertre; Ahmad Elbahnsi; Chandran Ka; Isabelle Callebaut; Gérald Le Gac
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

8.  Ferroportin disease mutations influence manganese accumulation and cytotoxicity.

Authors:  Eun-Kyung Choi; Trang-Tiffany Nguyen; Shigeki Iwase; Young Ah Seo
Journal:  FASEB J       Date:  2018-09-24       Impact factor: 5.834

9.  Epigenetic Regulation of Ferroportin in Primary Cultures of the Rat Blood-Brain Barrier.

Authors:  Steinunn Sara Helgudottir; Lisa J Routhe; Annette Burkhart; Katrine Jønsson; Inge S Pedersen; Jacek Lichota; Torben Moos
Journal:  Mol Neurobiol       Date:  2020-06-15       Impact factor: 5.682

Review 10.  Ferroportin disease: pathogenesis, diagnosis and treatment.

Authors:  Antonello Pietrangelo
Journal:  Haematologica       Date:  2017-11-03       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.